Results of Annual General Meeting
Released
Released
Announcement PDF
ASX ANNOUNCEMENT
16 NOVEMBER 2023
Results of Annual General Meeting
Sydney, Australia – 16 November 2023 – Radiopharm Theranostics (ASX:RAD), a developer of a worldclass platform of radiopharmaceutical products for both diagnostic and therapeutic uses, advises that all
resolutions at the Annual General Meeting held today were carried on a poll.
In accordance with ASX Listing Rule 3.13.2 and Section 251AA of the Corporations Act 2001, details of
the proxies received and votes cast in respect of each resolution are attached.
Phillip Hains
Joint Company Secretary
Radiopharm Theranostics Limited
Suite 1, Level 3, 62 Lygon Street, Carlton South VIC 3053 Australia
ABN: 57 647 877 889
Disclosure of Proxy Votes
Automic
GPO Box 5193, Sydney, NSW 2001
P 1300 288 664 (aus) or +61 (0)2 9698 5414 (world)
F +61 (0)2 8583 3040 E hello@automic.com.au
ABN 27 152 260 814
Radiopharm Theranostics Limited
Annual General Meeting
Thursday, 16 November 2023
In accordance with section 251AA of the Corporations Act 2001, the following information is provided in relation to resolutions put to members at the meeting.
Poll Results (if
applicable)
Proxy Votes
Resolution
Decided by
Show of
Hands (S) or
Poll (P)
Total Number of
Proxy Votes
exercisable by
proxies validly
appointed
1 Remuneration Report
P
43,500,170
2 Re-election of Director – Dr Michael Baker
P
144,014,867
3 Approval to issue Incentive Options to Director – Mr
Paul Hopper
P
43,564,170
4 Approval to issue Incentive Options to Director – Mr
Riccardo Canevari
P
43,564,170
5 Approval to issue Incentive Options to Director – Mr
Ian Turner
P
43,564,170
6 Approval of 10% capacity under Listing Rule 7.1A
P
144,158,367
7 Approval to issue Equity Securities under Omnibus
Incentive Plan
P
43,562,170
8 Amendment to Constitution
P
136,002,826
FOR
AGAINST
32,704,989
10,769,681
75.18%
24.76%
105,413,922
10,280,314
73.20%
7.14%
31,668,576
11,870,094
72.69%
27.25%
32,202,560
11,336,110
73.92%
26.02%
31,643,576
11,895,094
72.64%
27.30%
104,290,704
11,547,032
72.34%
8.01%
31,660,935
11,875,735
72.68%
27.26%
104,025,143
3,657,052
76.49%
2.69%
ABSTAIN
66,857
148,357
94,224,285
100,599,054
94,224,285
4,857
100,601,054
8,160,398
PROXY'S
DISCRETION
FOR
AGAINST
25,500
37,110,101
10,769,681
0.06%
77.51%
22.49%
28,320,631
138,114,165
10,280,314
19.67%
93.07%
6.93%
25,500
36,073,688
11,870,094
0.06%
75.24%
24.76%
25,500
36,607,672
11,336,110
0.06%
76.36%
23.64%
25,500
36,048,688
11,895,094
0.06%
75.19%
24.81%
28,320,631
136,990,947
11,547,032
19.65%
92.23%
7.77%
25,500
36,066,047
11,875,735
0.06%
75.23%
24.77%
28,320,631
136,725,386
3,657,052
20.82%
97.39%
2.61%
Results
ABSTAIN
OUTCOME
66,857
-
148,357
Passed
94,224,285
Passed
100,599,054
Passed
94,224,285
Passed
4,857
Passed
100,601,054
Passed
8,160,398
Passed
Share your feedback
Discover